Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Lehmann
Thomas Lehmann
Novartis
Medicine
Panobinostat
Antibody-dependent cell-mediated cytotoxicity
Molecular biology
SLAMF7
2
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials.
2020
The Lancet Respiratory Medicine
Christopher E. Brightling
Mina Gaga
Hiromasa Inoue
Jing Li
Jorge Maspero
Sally E. Wenzel
Samopriyo Maitra
David Lawrence
Florian Brockhaus
Thomas Lehmann
Caterina Brindicci
Barbara Knorr
Eugene R. Bleecker
Show All
Source
Cite
Save
Citations (31)
Panobinostat Induces Upregulation of CD38 and Augments the Anti-Myeloma Efficacy of Daratumumab in Pre-Clinical Models
2016
Blood
Estefanía García-Guerrero
Tea Gogishvili
Sophia Danhof
Martin Schreder
Celine Pallaud
Thomas Lehmann
Hermann Einsele
Michael Hudecek
Show All
Source
Cite
Save
Citations (1)
1